Learn how H. pylori, HPV, hepatitis B and C, and the virus behind mono can lead to cancer, and how vaccines and treatment can reduce risk.
A new AI-based model can predict where glioblastoma is most likely to return after initial surgery, potentially giving doctors a chance to treat it before it becomes visible on MRI.
New electronic skin combines sensing and visualisation in a single device, enabling high-resolution mapping of touch for healthcare and robotics applications
DALLAS, Sept. 28, 2026 /PRNewswire/ — Insera Therapeutics, Inc., a medical device company focused on advancing cyclical aspiration for mechanical thrombectomy, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the CLEAR™ Aspiration System.
The scent of your belly button, nose, or ear may one day be used to make medical diagnosis.
Immunotherapy, which uses a patient’s immune system to treat disease, has increased survival for some adults and children with cancer. However, it has had limited success against many pediatric solid tumors, in part because T cells can become functionally impaired or “exhausted.” St. Jude Children’s Research Hospital scientists published results in Nature showing that the gene ZMYND8 is a major regulator of CD8+ T-cell exhaustion.
What can mathematics reveal about Alzheimer’s disease? Mississippi State University associate professor Shantia Yarahmadian is using mathematical modeling to examine how common metals may influence a protein that forms plaque associated with Alzheimer’s disease—and how potential therapies could alter these processes.
Ovarian cancer is often diagnosed after it has already spread to other parts of the body, at which point the five-year survival rate is under 30%.
With a lot of ingenuity, some creative engineering and a few off-the-shelf items, a University of Florida team led by a virologist and an engineer has created an inexpensive, quick and accurate handheld device that can detect seven mosquito-borne illnesses
A new study from The Wistar Institute has found a link between the nervous system and the rapid development of neuroendocrine prostate cancer (NEPC), an aggressive form of the disease.